Leads Biolabs Gains Japan Orphan Drug Designation for Opamtistomig
NANJING, China — September 28, 2026 Leads Biolabs announced that opamtistomig (LBL-024), its investigational PD-L1/4-1BB bispecific antibody, has received...
MHLW
Advertisement
OncoC4 Receives FDA Fast Track for Cesalatamig
Rockville, Maryland, USA, September 16, 2026 OncoC4, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
Viatris WAKIX Approved in Japan for Sleep Disorders
Tokyo, Japan, September 16, 2026 Viatris Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved...
GSK Shingrix Prefilled Syringe Approved in Japan
London, United Kingdom, September 10, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
United Therapeutics Advances PAH and IPF Data at ESC, ERS
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, Aug 28, 2026 United Therapeutics Corporation announced that new clinical...
Advertisements
Takeda Wins Japan Approval for ORZEYFUL in Narcolepsy
OSAKA, Japan & CAMBRIDGE, Massachusetts, Aug 24, 2026 Takeda Pharmaceutical Company Limited announced that Japan’s Ministry of Health, Labour...
GSK Wins Japan Approval for Hibsago in Hepatitis B
LONDON, UK, Aug 24, 2026 GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved...
Apollo Therapeutics Reports Positive APL-10456 Phase 1 Data
BOSTON, U.S. & CAMBRIDGE, U.K. — August 25, 2026 Apollo Therapeutics announced positive immunogenicity and cross-species activity data from...
BioCryst Wins Japan Approval for Pediatric ORLADEYO
TOKYO, Japan — August 25, 2026 BioCryst Pharmaceuticals announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
Rhythm Pharmaceuticals Wins Japan Approval for IMCIVREE
BOSTON, August 24, 2026 Rhythm Pharmaceuticals, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted...
Advertisement
